 LOS ANGELES, July 28, 2021 PRNewswire -- Glancy Prongay Murray LLP GPM reminds investors of the upcoming September 7, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Orphazyme AS Orphazyme or the Company NASDAQ: ORPH a American Depositary Shares ADSs or shares pursuant andor traceable to the registration statement and prospectus collectively, the Registration Statement issued in connection with the Companys September 2020 initial public offering IPO or the Offering; andor b securities between September 29, 2020 and June 18, 2021 , inclusive the Class Period. If you suffered a loss on your Orphazyme investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at 